Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 8/20 | 0.54 |
| ▸ | ITGA2B | P08514 | 8/20 | 0.54 |
| ▸ | CTSK | P43235 | 8/20 | 0.46 |
| ▸ | CTSS | P25774 | 4/20 | 0.46 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
| ▸ | MMP2 | P08253 | 1/20 | 0.40 |
| ▸ | MMP9 | P14780 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8823986 | 0.96 | ITGB3 (0.54) | ITGB3ITGA2BCTSKCTSSHDAC4 | |
| SCHEMBL2324580 | 0.96 | ITGB3 (0.54) | ITGB3ITGA2BCTSKCTSSHDAC4 | |
| SCHEMBL1904291 | 0.96 | ITGB3 (0.54) | ITGB3ITGA2BCTSKCTSSHDAC4 | |
| Hydrochloric Acid SCHEMBL3056203 | 0.94 | ITGB3 (0.53) | ITGB3ITGA2BCTSKCTSSHDAC4 | |
| Hydrochloric Acid SCHEMBL27573111 | 0.94 | ITGB3 (0.53) | ITGB3ITGA2BCTSKCTSSHDAC4 | |
| Hydrochloric Acid SCHEMBL18982338 | 0.94 | ITGB3 (0.53) | ITGB3ITGA2BCTSKCTSSHDAC4 | |
| Hydrochloric Acid SCHEMBL28012371 | 0.94 | ITGB3 (0.53) | ITGB3ITGA2BCTSKCTSSHDAC4 | |
| Acetic Acid SCHEMBL11204426 | 0.93 | ITGB3 (0.48) | ITGB3ITGA2BCTSKCTSSHDAC4 | |
| SCHEMBL6646260 | 0.91 | ITGB3 (0.50) | ITGB3ITGA2BCTSKCTSSHDAC4 | |
| SCHEMBL14366085 | 0.91 | ITGB3 (0.50) | ITGB3ITGA2BCTSKCTSSHDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12269797-B2 | Bifunctional linker for bisconjugation, method of synthesis, and method of use | THE JOHNS HOPKINS UNIVERSITY (US) | 2025-04-08 | — | — | US | disclosed |
| US-20240051897-A1 | SYNTHESIS OF COMPLEX 15N-LABELED MOLECULES | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2024-02-15 | — | — | US | disclosed |
| US-20220106255-A1 | BIFUNCTIONAL LINKER FOR BISCONJUGATION, METHOD OF SYNTHESIS, AND METHOD OF USE | THE JOHNS HOPKINS UNIVERSITY | 2022-04-07 | — | — | US | disclosed |
| US-20040235752-A1 | 3-fluoro-pyrrolidines as antidiabetic agents | FERRING B.V. (NL) | 2004-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040235752-A1 | 3-fluoro-pyrrolidines as antidiabetic agents | DPP4, DPP7, DPP3 | ITGB3 3366/4885ITGA2B 4014/4885CTSK 199/4885 |
| US-20240051897-A1 | SYNTHESIS OF COMPLEX 15N-LABELED MOLECULES | NCLN, NCL, NDUFV3 | ITGB3 2537/4885ITGA2B 3418/4885CTSK 3938/4885 |
| US-12269797-B2 | Bifunctional linker for bisconjugation, method of synthesis, and method of use | C1R, C9, FCGRT | ITGB3 576/4885ITGA2B 1141/4885CTSK 4442/4885 |
| US-20220106255-A1 | BIFUNCTIONAL LINKER FOR BISCONJUGATION, METHOD OF SYNTHESIS, AND METHOD OF USE | C1R, C9, FCGRT | ITGB3 576/4885ITGA2B 1141/4885CTSK 4442/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.